Image

Phase I/II Study of Ixazomib and Romidepsin in Relapsed/ Refractory Peripheral T-cell Lymphoma (PTCL)

Study on the Safety and Effectiveness of an Investigational Drug Combination for Peripheral T-cell Lymphoma

Recruiting
18 years and older
All
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates the safety and effectiveness of combining two investigational medications for treating peripheral T-cell lymphoma (PTCL), a type of cancer that affects the lymphatic system. The purpose is to determine how safe the combination is and how well it works in resolving tumors.

Participants in the study will receive the investigational medications and their response will be measured. The study will look at the percentage of patients whose tumors completely go away after receiving the treatment.

  • Who can participate: Adults aged 18 years or older with a confirmed diagnosis of peripheral T-cell lymphoma are eligible to participate.
  • Study details: Participants will receive the investigational combination of medications. The study will evaluate the safety and efficacy of this treatment.
Print
Study details
    Peripheral T-cell Lymphoma (PTCL)

TX10450

19 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Please provide your preferred way of contact1234
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.